Analysts expect Hydrogenics Co. (NASDAQ:HYGS) (TSE:HYG) to post sales of $10.05 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Hydrogenics’ earnings, with estimates ranging from $10.00 million to $10.10 million. Hydrogenics posted sales of $19.53 million in the same quarter last year, which suggests a negative year-over-year growth rate of 48.5%. The firm is expected to announce its next quarterly earnings report on Thursday, March 14th.
On average, analysts expect that Hydrogenics will report full year sales of $33.45 million for the current financial year, with estimates ranging from $33.40 million to $33.50 million. For the next year, analysts anticipate that the company will post sales of $43.50 million, with estimates ranging from $38.00 million to $49.00 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that cover Hydrogenics.
Hydrogenics (NASDAQ:HYGS) (TSE:HYG) last announced its quarterly earnings results on Friday, November 2nd. The energy company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.15). Hydrogenics had a negative return on equity of 58.33% and a negative net margin of 26.37%. The business had revenue of $7.67 million for the quarter, compared to analysts’ expectations of $13.75 million.
A number of research firms have weighed in on HYGS. ValuEngine cut shares of Hydrogenics from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 18th. HC Wainwright set a $8.00 price objective on shares of Hydrogenics and gave the company a “buy” rating in a research report on Monday, November 5th. Roth Capital restated a “buy” rating on shares of Hydrogenics in a research note on Wednesday, October 31st. Zacks Investment Research upgraded shares of Hydrogenics from a “sell” rating to a “hold” rating in a research note on Tuesday, January 8th. Finally, Canaccord Genuity began coverage on shares of Hydrogenics in a research note on Wednesday. They issued a “speculative buy” rating and a $8.75 target price on the stock. Two research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $8.81.
Hydrogenics stock traded up $0.45 during trading on Monday, reaching $6.55. 76,744 shares of the company’s stock were exchanged, compared to its average volume of 64,782. Hydrogenics has a 52-week low of $3.80 and a 52-week high of $10.85. The stock has a market cap of $94.23 million, a price-to-earnings ratio of -8.19 and a beta of 0.23.
Several institutional investors have recently modified their holdings of HYGS. Renaissance Technologies LLC acquired a new stake in Hydrogenics during the third quarter worth about $133,000. Emancipation Management LLC acquired a new stake in Hydrogenics during the third quarter worth about $188,000. Finally, Heartland Advisors Inc. raised its stake in Hydrogenics by 7.7% during the third quarter. Heartland Advisors Inc. now owns 1,018,042 shares of the energy company’s stock worth $7,381,000 after acquiring an additional 73,042 shares during the period. Institutional investors and hedge funds own 16.13% of the company’s stock.
Hydrogenics Company Profile
Hydrogenics Corporation, together with its subsidiaries, designs, develops, and manufactures hydrogen generation products based on water electrolysis technology; and fuel cell products based on proton exchange membrane technology. It operates in two segments, OnSite Generation and Power Systems. The OnSite Generation segment develops products for industrial gas, hydrogen fueling, and renewable energy storage markets.
Recommended Story: How do taxes affect a CDs total return?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hydrogenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hydrogenics and related companies with MarketBeat.com's FREE daily email newsletter.